General Information of the Compound
| Compound ID |
CP0160473
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-(4-(2-(1H-pyrazol-3-ylamino)-1H-benzo[d]imidazol-1-yl)-6-methyl-1,3,5-triazin-2-ylamino)acetonitrile
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H14N10
|
||||||||||||||||||
| Molecular Weight |
346.358
|
||||||||||||||||||
| Canonical SMILES |
Cc1nc(NCC#N)nc(n1)-n1c(Nc2ccn[nH]2)nc2ccccc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H14N10/c1-10-20-14(18-9-7-17)24-15(21-10)26-12-5-3-2-4-11(12)22-16(26)23-13-6-8-19-25-13/h2-6,8H,9H2,1H3,(H,18,20,21,24)(H2,19,22,23,25)
Show/Hide
|
||||||||||||||||||
| InChIKey |
XPLCDRVACNNQQT-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01065, Serine/threonine-protein kinase mTOR
Cell Viability or Cytotoxicity Assay